Olverembatinib dimesylate
Product Specifications
CAS Number
1421783-64-3
Target
Bcr-Abl
Related Pathways
Cytoskeletal Signaling, Tyrosine Kinase/Adaptors, Angiogenesis
Purity
>99.99%
Bioactivity
Olverembatinib dimesylate (GZD824 Dimesylate) is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl (WT) and Bcr-Abl (T315I) .
Smiles
CS(O)(=O)=O.CS(O)(=O)=O.CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4[nH]ncc4c3)cc2C(F)(F)F)CC1
Molecular Formula
C29H27F3N6O·2CH4O3S
Molecular Weight
724.77
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP51365PU-N 400 µL
Endothelin 1 (EDN1) (C-term) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
BNC881951-100 1x 100 µL
Bcl-6 (Follicular Lymphoma Marker) (BCL6/1951R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
![Elab Fluor® 647 Anti-Human CD4 Antibody[RPA-T4]](https://cdn.genprice.uk/products/763/68dd14af061270361e7d3738/imageurl/e-ab-f1109m.webp)
E-AB-F1109M-01 20 Tests
Elab Fluor® 647 Anti-Human CD4 Antibody[RPA-T4]
Sign In for Pricing
View Details